Ashland Q4 adjusted profit misses estimates; forecasts higher 2027 sales
ASH•Ashland reported fiscal fourth-quarter revenue of $498 million, up 4% but slightly below estimates, and adjusted EPS of $1.12, below the $1.28 consensus. It forecast fiscal 2027 sales of $1.905 billion to $1.975 billion and adjusted EBITDA of $405 million to $435 million.
1. Quarterly results
Ashland’s fiscal fourth-quarter revenue rose 4% to $498 million, slightly below the $501.81 million estimate. Adjusted EPS increased to $1.12 from $1.08 a year earlier but missed the $1.28 consensus. The company reported a net loss of $16 million, compared with net income a year earlier.
2. Fiscal 2027 outlook
Ashland forecast fiscal 2027 sales of $1.905 billion to $1.975 billion and adjusted EBITDA of $405 million to $435 million. It expects resilient demand in Life Sciences and Personal Care.
3. Business drivers
Higher sales volumes in Life Sciences and Personal Care supported fourth-quarter results, while pricing actions offset higher raw material costs. Lower Hopewell productivity and unfavorable absorption reduced Specialty Additives earnings.
